Plus: exercise capacity and lifespan; SGLT-2 vs GLP-1; more
Saturday, Oct. 3, 2020 : Issue #1068 TOP STORIES - Diabetes News & Research |
|
Letter from the Editor
A lot of people have stayed away from gyms over the past 6 months, and many have had to adapt their exercise regimens. Some of our patients are now returning to the gym and are wanting to build back the muscle they have lost. Too many times, patients will think that they need extra protein and overdo it.
This week, Dr. Sheri Colberg has a feature on how your patients can determine the right protein choices and amounts to maximize muscle growth, and why protein timing can actually be very beneficial for glucose control.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
In Our Next Issue: How AI is Innovating Diabetes Care
Don't miss part 1 of this exclusive 3-part special report. Adherence-related issues are hemorrhaging the costs of diabetes-related treatment in America. To offset this tragedy, GlucosePATH is utilized by a team of healthcare professionals dedicated to improving the quality of life while decreasing avoidable costs. |
TOP STORIES - Diabetes News and Research |
|
| Pumping Up with Protein: Does This Work for Exercise and Health?By Sheri Colberg, PhD
Protein is never a key exercise fuel, but it’s critical for other reasons. During most exercise, protein contributes less than 5 percent of the total energy, although it may rise to 10 to 15 percent during a prolonged event like a marathon or Ironman triathlon. Taking in enough dietary protein is important because dietary protein allows your muscles to be repaired after exercise and promotes the synthesis of hormones, enzymes, and other body tissues formed from amino acids, the building blocks of protein. |
| |
|
|
|
|
| Did You Know? Greater exercise capacity could mean longer life for adults with type 2 diabetes:
Among people with type 2 diabetes, those with increased exercise capacity had a significantly decreased risk for all-cause mortality, according to data presented at the virtual EASD annual meeting. Previous studies had demonstrated that exercise could improve insulin sensitivity and inhibit inflammatory cytokines, thereby reversing the pathogenesis of type 2 diabetes. Epidemiologic studies had also shown that exercise reduced risk for cardiovascular events and mortality risks. However, the dose of exercise capacity for reducing mortality risk in people with type 2 diabetes was not yet well investigated. Data was analyzed from 4859 adults with type 2 diabetes (49% men; mean age, 60 years), using data from the National Health Interview Survey. Researchers used Kaplan-Meier curves and Cox proportional hazard analyses to evaluate the relationship between exercise capacity and all-cause mortality.
Compared with those with no exercise habits, individuals with a moderate exercise level, defined as 0 kcal to 800 kcal per week, had a 25% lower all-cause mortality risk (HR = 0.75; 95% CI, 0.62-0.91), whereas those with a high exercise level, defined as more than 800 kcal per week, had a 32% lower all-cause mortality risk (HR = 0.68; 95% CI, 0.57-0.81). Whether you can reduce mortality by 25% with moderate exercise or by 32% with a higher exercise level, exercise is critical for those with type 2 diabetes.
Lai Y-J et al. Abstract #267. Presented at: EASD Annual Meeting; Sept. 21-25, 2020 (virtual meeting) |
|
|
| Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: Tarshay Boyd, PharmD. Candidate, LECOM School of Pharmacy David Clarke, PharmD Candidate, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences George McConnell, PharmD. Candidate, LECOM School of Pharmacy Shadrielle Robbins, PharmD Candidate, South College School of Pharmacy |
|
|
|
|
|
| | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
